摘要
Hyperglycemia in pregnancy is one of the most common pregnancy disorders, including gestational diabetes mellitus （GDM） and diabetes in pregnancy （DIP）. Either preexisting diabetes （Type I or Type II） which antedates pregnancy or is first detected during pregnancy, it is associated with adverse outcomes both in mother and child, not only for the short-term consequences but also for the long-term consequences. During the past few decades, some progress has been achieved in the management in hyperglycemia in pregnancy, and severe complications of mothers and offspring were significantly reduced.
Hyperglycemia in pregnancy is one of the most common pregnancy disorders, including gestational diabetes mellitus （GDM） and diabetes in pregnancy （DIP）. Either preexisting diabetes （Type I or Type II） which antedates pregnancy or is first detected during pregnancy, it is associated with adverse outcomes both in mother and child, not only for the short-term consequences but also for the long-term consequences. During the past few decades, some progress has been achieved in the management in hyperglycemia in pregnancy, and severe complications of mothers and offspring were significantly reduced.
